Sundance Pharmaceuticals will be conducting clinical studies for FDA approvals of an emergency room intravenous treatment to prevent disability and early death from concussion and traumatic brain injury, a combination pharmaceutical- and cannabis-derived medication for treatment of acute and chronic pain that does not result in opioid dependence, and a cannabis-derived home treatment for opioid dependence that is to be confidential and provided at no cost to the patient.

Sundance Pharmaceuticals is inspired by the life of Thomas Duff Lilly, beloved son and only child of co-founder Kim Bechthold.   Mr. Lilly was injured by four concussions in his lifetime and developed Chronic Traumatic Encephalopathy as a result.  Spirited and possessed of great courage, Mr. Lilly skied, hiked, bicycled and danced like a “wild man,” despite his injuries.   His family, friends and loved ones remember his great laugh, his love of his Golden Retrievers, the 49ers, Broncos and the Rockies, music, holidays, and his extraordinary, uncompromising will never to give up and to live life to the fullest every hour of every day.

Sundance Pharmaceuticals
415 533-5696
Suite 485
336 Bon Air Center
Greenbrae, CA 94904